Department of Breast Cancer Internal Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Cancer Med. 2024 Feb;13(4):e6749. doi: 10.1002/cam4.6749.
To assess fear of progression (FoP)'s relationship with symptom burden and disease and social/family factors, as well as, determine the status of FoP in women with stage-IV breast cancer in Shandong, China.
Two hundred and sixteen women were recruited from the department of breast cancer internal medicine, Shandong Cancer Hospital and Institute. Data for this observational study were collected between October 2020 and January 2021 using the MD Anderson Symptom Inventory, the Fear of Progression Questionnaire-Short Form (FoP-Q-SF) and a participant information scale. SPSS 23.0 was used for statistical analysis.
After excluding invalid responses, the data of 200 participants were analysed. The average total FoP-Q-SF score was 29.39 ± 9.39 (95% confidence interval, 21.81-27.64). The FoP level among the participants was relatively low. For disease and social/family factors, FoP statistically significantly differed by satisfaction with family emotional support and the Eastern Cooperative Oncology Group (ECOG) score. The ECOG score was positively correlated with FoP. Furthermore, symptom burden was positively correlated with FoP.
Among patients with stage-IV breast cancer, satisfaction with family emotional support, ECOG score and symptom burden play key roles in FoP. Interventions, including providing appropriate emotional support from family, improving physical fitness and relieving symptom burden, must be considered in future studies, which may improve patients' overall physical and mental status and provide a supportive therapeutic environment.
评估进展恐惧(FoP)与症状负担和疾病及社会/家庭因素的关系,并确定中国山东 IV 期乳腺癌女性的 FoP 现状。
从山东省肿瘤医院乳腺内科招募了 216 名女性。本观察性研究的数据于 2020 年 10 月至 2021 年 1 月期间通过 MD 安德森症状量表、进展恐惧问卷-短表(FoP-Q-SF)和参与者信息量表收集。使用 SPSS 23.0 进行统计分析。
剔除无效回复后,分析了 200 名参与者的数据。FoP-Q-SF 总分的平均得分为 29.39±9.39(95%置信区间,21.81-27.64)。参与者的 FoP 水平相对较低。在疾病和社会/家庭因素方面,FoP 在家庭情感支持满意度和东部合作肿瘤组(ECOG)评分方面存在统计学差异。ECOG 评分与 FoP 呈正相关。此外,症状负担与 FoP 呈正相关。
在 IV 期乳腺癌患者中,家庭情感支持满意度、ECOG 评分和症状负担在 FoP 中起着关键作用。在未来的研究中,必须考虑包括提供适当的家庭情感支持、改善身体健康和减轻症状负担等干预措施,这可能会改善患者的整体身心状况,并提供支持性的治疗环境。